1380P Phase (Ph) II Study of Zanidatamab + Chemotherapy (Chemo) in First-Line (1L) HER2 Expressing Gastroesophageal Adenocarcinoma (GEA) - Ku, G; Elimova, E; Denlinger, CS (Ann Oncol, 2021)
et al.